pwird.com
Before the end of the year, we are sending our last reminder! We would like to thank you for your participation and kindly ask, for one last time, to inform your members of our questionnaire.
The study is going very well so far, we have had almost 400 responses from 26 different countries. The greater the participation, the more information we will have that could possibly be representative of each country; thus, we would like to extend our study until December 15th. Our aim is to investigate the pregnancy experience that women with rheumatic diseases go through, in order to voice their concerns, reveal problems they’ve faced and identify areas of improvement of the health system, and we are close to finalising our efforts. Please share our questionnaire through email, Facebook, website-link or other way of your preference.
Attached please find the links to our questionnaires:
We deeply appreciate your support!
Kind regards,
Ilianna Armata 3rd yr medical student
J. Joseph Associate Professor
St George’s University of London programme at the University of Nicosia Medical School, Cyprus.

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

🚨 New publication alert: EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement- 2025 update.

‼️ According to Lupus Europe's 2024 Swiss knife survey:

1️⃣ Kidney involvement remains one of the most worrying and impactful lupus manifestations for many people in Europe.
2️⃣ Kidney problems are among the manifestations causing the greatest long-term concern.
3️⃣ Only a small minority of patients report long-term stability without flares.
4️⃣ Patients want clearer goals, better communication, and care that looks beyond lab values alone.

That is why the 2025 update of the EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement is such an important step forward.

✅ These updated recommendations reinforce several key messages that matter to patients:
- Early and regular monitoring of kidney involvement.
- Timely kidney biopsy when needed.
- Clear treatment targets to preserve kidney function.
- A strong focus on combination therapies when appropriate.
- Long-term kidney protection, not only short-term control.

🌟 We are especially proud that our Chair, Jeanette Andersen, was part of the international task force that developed these recommendations, ensuring that the patient perspective was present at the table.

You can read the EULAR Recommendations here: ard.eular.org/article/S0003-4967(25)04412-7/fulltext

And the Swiss Knife Survey here: www.sciencedirect.com/science/article/pii/S1568997225000989
... See MoreSee Less

🚨 New publication

😃 Thank you to all who attended our latest Youth Group webinar!

🌟 So many interesting questions were asked and addressed! Showing how important safe spaces arefor talking openly about lupus without judgment.

Did you miss it? Watch it here! 👇

Alcohol & Drugs - Lupus
... See MoreSee Less

😃 Thank you to al

🚨 𝗟𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲❗

🙏 Help Prof Laurent Arnaud and his team validate the Lupus Brain Fog Severity Scale.

✅ Make lupus brain fog measurable.

⏱️ 5 minutes of your time can make a huge impact!

lupusresearch.limequery.org/337533?lang=en
... See MoreSee Less

🚨 𝗟𝗮𝘀�
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send